- Joined
- Sep 2, 2024
- Messages
- 1,261
- Reaction score
- 3,333
Or for Eli Lilly' take, read its press release: Lilly's oral GLP-1, orforglipron, demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines in successful Phase 3 trial
I wouldn't switch to orforglipron, however many folks likely avoid GLP-1 drugs due to a desire to avoid injecting themselves. Perhaps this drug will be more affordable than the good weight loss drugs now out there.I can see how this would be helpful for maintenance but they just seem to be a lot less effective than the injectables. 7.9% weight loss at 40 weeks (highest dose) is kind of a tough sell given the results with the others. Although this is associated with no plateaus. Wonder what this will look like at 68-72 weeks.